Welcome to our dedicated page for Oxford Square Capital SEC filings (Ticker: OXSQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Oxford Square Capital's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Oxford Square Capital's regulatory disclosures and financial reporting.
Oxford Square Capital Corp. is soliciting proxies for its 2026 annual meeting to elect two directors and ratify Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. The meeting is scheduled for August 20, 2026, at the company’s Greenwich, Connecticut headquarters.
Stockholders of record as of June 30, 2026 may vote, with 105,058,242 common shares outstanding, each entitled to one vote. The board, including all independent directors, unanimously recommends voting “FOR” the election of Steven P. Novak and Charles M. Royce and “FOR” ratifying Ernst & Young. PricewaterhouseCoopers was dismissed as auditor in May 2026, with no reported disagreements or reportable events, and audit fees for 2025 totaled $1,015,576.
Oxford Square Capital Corp. has changed its independent auditor, dismissing PricewaterhouseCoopers LLP and appointing Ernst & Young LLP. The board of directors approved this move based on the audit committee’s recommendation.
PWC’s audit reports on the company’s financial statements for the years ended December 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements with PwC on accounting, disclosure, or audit scope, and no reportable events during those periods. PwC provided a confirming letter to the SEC, which is attached as an exhibit.
Oxford Square Capital Corp. President and COO Saul B. Rosenthal bought shares of the company in the open market. On May 20, 2026, he purchased 144,703 shares of common stock at a weighted average price of $1.1517 per share in an open-market transaction.
The purchased shares were acquired into a joint tenants in common account in which Rosenthal has a 50% pecuniary interest, with CEO Jonathan H. Cohen holding the other 50%. After this transaction, Rosenthal directly owned 2,201,479 common shares and indirectly held 1,898 shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. Chief Executive Officer Jonathan H. Cohen reported an open-market purchase of 144,704 shares of common stock at a weighted average price of $1.1517 per share on May 20, 2026. The shares were bought into a joint tenants in common account in which Cohen has a 50% pecuniary interest and President and COO Saul B. Rosenthal holds the other 50%. Following this transaction, Cohen directly owns 2,417,193 common shares and indirectly holds 1,898 additional shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.
Oxford Square Capital Corp. amended its charter to expand its flexibility to issue stock in the future. The company increased its total authorized capital stock from 100,000,000 shares to 300,000,000 shares, all designated as common stock with a par value of $0.01 per share. The Articles of Amendment were filed with the Maryland State Department of Assessments and Taxation and became effective immediately upon filing.
Oxford Square Capital Corp. filed an 8-K describing amendment no. 1 to its amended and restated equity distribution agreement with Oxford Square Management, Oxford Funds, Lucid Capital Markets and Ladenburg Thalmann as sales agents. The amendment allows sales of common stock to continue under the company’s effective Form N-2 shelf registration statement, supported by a new prospectus supplement dated May 5, 2026.
The company also filed a legality opinion from Dechert LLP covering shares to be sold pursuant to the amended equity distribution agreement, together with related consent and technical XBRL exhibit items.
Oxford Square Capital Corp. filed a prospectus supplement to offer up to $150,000,000 of common stock under an amended "at-the-market" equity distribution agreement with Lucid Capital Markets and Ladenburg Thalmann. The program permits sales from time to time, with sales agents paid the lesser of 2.0% or the spread to NAV. As of April 30, 2026, 93,527,087 shares were outstanding and the company reported a net asset value of $1.32 per share as of March 31, 2026. From August 1, 2019 to April 30, 2026, the company sold 37,794,797 shares under its prior ATM program, raising approximately $96.0 million in gross proceeds (net proceeds ~$94.1 million). Proceeds from any sales will be used to fund investments aligned with the BDC’s strategy or held temporarily in high-quality short-term investments. The offering may result in dilution and shares can trade at discounts to NAV.
Oxford Square Capital Corp. reports weaker Q1 2026 results, with net assets falling to $123.3 million from $145.4 million at year-end 2025 and net asset value per share declining from $1.69 to $1.32. Total assets were $278.9 million, including $235.4 million of investments at fair value and $40.6 million in cash equivalents.
The company generated net investment income of $4.15 million, or $0.05 per share, but realized losses of $30.7 million and modest unrealized gains of $1.1 million drove a net decrease in net assets from operations of $25.5 million, or $(0.29) per share. Distributions totaled $0.105 per share for the quarter.
The portfolio remains heavily invested in senior secured loans and CLO equity. CLO equity fair value declined to about $72.2 million, and aggregate net unrealized depreciation on investments reached roughly $147.7 million versus tax cost. Operating cash flow was negative at $14.4 million, while common stock issuance provided $12.3 million of new equity. Qualifying assets represented 74.5% of total assets, above the BDC regulatory threshold.
Oxford Square Capital Corp. reported first quarter 2026 results and declared monthly common stock distributions of $0.035 per share for July, August, and September 2026. These payments have record dates of July 17, August 17, and September 16, 2026, respectively.
For the quarter ended March 31, 2026, the company generated total investment income of $8.9 million and net investment income of $4.1 million, or $0.05 per share. Large realized losses on investments of $30.7 million, partially offset by $1.1 million of unrealized gains, led to a net decrease in net assets from operations of $25.5 million, or $0.29 per share.
Net asset value per share fell from $1.69 at December 31, 2025 to $1.32 at March 31, 2026, and total return based on NAV was (15.68)% for the quarter. Total assets were $278.9 million and net assets were $123.3 million as of March 31, 2026.